Evidence map›Paper›PMID 37001817›Full record

ArticleJournal of thrombosis and haemostasis : JTH2023

Fibrinogen γ' promotes host survival during Staphylococcus aureus septicemia in mice.

Oscar Negrón, Miranda Weggeman, Jos Grimbergen, Emily G Clark, Sara Abrahams, Woosuk S Hur, Jaap Koopman, Matthew J Flick

Open access · hybridAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. CAUTIon - not all UTIs are the same.Nature reviews. Urology · 2025
    Review
  5. Article
  6. Metabolites · 2025
    Review
  7. Regulation of fibrinogen synthesis.Thrombosis research · 2024
    Review
  8. Observational
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Oscar NegrónDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Miranda WeggemanFibriant BV, Leiden, The Netherlands.
Jos GrimbergenFibriant BV, Leiden, The Netherlands.
Emily G ClarkDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Sara AbrahamsDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Woosuk S HurDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Jaap KoopmanFibriant BV, Leiden, The Netherlands.
Matthew J FlickDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Electronic address: matthew_flick@med.unc.edu.
University of North Carolina at Chapel Hill · US

Funding

Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19R01HL160046 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FLICK, MATTHEW J., GRALINSKI, LISA · 2021 to 2024
$2.2M
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma diseaseR01CA211098 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FLICK, MATTHEW J. · 2017 to 2022
$2.2M
Fibrin(ogen) control of metabolic inflammation and obesityR01DK112778 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FLICK, MATTHEW J. · 2019 to 2022
$1.5M
NCI NIH HHS R01 CA211098NHLBI NIH HHS R01 HL160046NIDDK NIH HHS R01 DK112778
6 · The paper itself

Abstract

backgroundStaphylococcus aureus is a common gram-positive bacterium that is the causative agent for several human diseases, including sepsis. A key virulence mechanism is pathogen binding to host fibrinogen through the C-terminal region of the γ-chain. Previous work demonstrated that Fgg

objectiveDetermine if human fibrinogen γ'-γ confers host protection during S. aureus septicemia.

methodsAnalyses of survival and the host response following S. aureus septicemia challenge in Fgg

resultsReconstitution of fibrinogen-deficient or wildtype mice with purified phFibγ'-γ prior to infection provided a significant prolongation in host survival relative to mice reconstituted with purified phFibγ-γ, which was superior to that observed with heterozygous Fgg

conclusionThese findings provide the proof-of-concept that changing the ratio of naturally occurring fibrinogen variants in blood could offer significant therapeutic potential against bacterial infection and potentially other diseases.

Indexed as

BacteremiaFibrinogens, AbnormalSepsisStaphylococcal InfectionsAnimalsFibrinogenHumansMiceStaphylococcus aureusFibrinogenfibrinogen gamma'Fibrinogens, AbnormalbacteremiafibrinogenS. aureussepsis

Identifiers

PMID37001817
PMCPMC10528022
OpenAlexW4361228620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.